Vijay Kasturi

An accomplished hematologist-oncologist and researcher, Dr Vijay Kasturi oversees the medical affairs team at FerGene. For more than 25 years Vijay has built a stellar career establishing and executing global and regional strategies that have brought innovative new treatment options to patients in immunology, hematology and oncology.

Prior to joining FerGene, Vijay led US medical affairs, Oncology for EMD Serono where he had broad leadership responsibilities, including external stakeholder management, evidence generation, medical education and publication strategy. During his time with EMD Serono, Vijay also developed and managed the global medical strategy and integrated development plan for the company’s anti-PD-L1 agent (avelumab), including indications in Merkel cell, urothelial, and kidney cancer.

Earlier in this career, he served as an assistant professor of medicine, Division of Hematology-Oncology at the University of Massachusetts Medical School and was the program leader for genitourinary oncology at UMass Memorial Cancer Center. He trained in Hematology-Oncology at the National Cancer Institute and worked as an investigator and physician at the National Cancer Institute and at Dartmouth Hitchcock Medical Center.

He has authored more than 15 publications and posters and has been the recipient of numerous awards for his work in medicine.